CLINICAL_TRIALS
trial_result
· 2019-12-17
Clinical Trial Update: Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial comparing semaglutide to canagliflozin as add-on to metformin in adults with type 2 diabetes; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2019-12-17